2. Academic Validation
  3. OAS cross-activates RNase L intercellularly through cell-to-cell transfer of 2-5A to spread innate immunity

OAS cross-activates RNase L intercellularly through cell-to-cell transfer of 2-5A to spread innate immunity

  • Immunity. 2025 Apr 8;58(4):797-810.e6. doi: 10.1016/j.immuni.2025.01.016.
Wanwan Huai 1,  Kun Yang 1,  Cong Xing 1,  Kun Song 1,  Heng Lyu 1,  Noelle S Williams 2,  Jianjun Wu 3,  Nan Yan 4
Affiliations

Affiliations

  • 1 Department of Immunology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • 2 Department of Biochemistry, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • 3 Center for Immunotherapy & Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: wuj9@ccf.org.
  • 4 Department of Immunology, UT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: nan.yan@utsouthwestern.edu.
PMID: 40010341 DOI: 10.1016/j.immuni.2025.01.016
Abstract

The 2',5'-oligoadenylate synthetase (OAS)-RNase L pathway is a classical Antiviral innate immune pathway. Upon sensing dsRNA, OAS produces 2',5'-oligoadenylate (2-5A) as a second messenger to activate RNase L. Whether 2-5A can be transported to extend the reach of innate immune signaling has not been established. Here, we showed that 2-5A was transferred from cell to cell through connexin (CX43/CX45) gap junctions. 2-5A was also transferred through importers and exporters, allowing OAS to remotely activate RNase L and protect neighboring cells from viral Infection. We identified ABCC10 as a 2-5A exporter. Loss of ABCC10 had no effect on 2-5A production but reduced 2-5A export and protection of neighboring cells. Furthermore, OAShi tumors such as MC38 naturally produced 2-5A in vivo, which was secreted via ABCC10 to activate host-not tumor-RNase L-mediated antitumor response. Therefore, 2-5A is an immunotransmitter that mediates short-range communication between cells in Infection and Cancer.

Keywords

2-5A; ABCC10; OAS; RNase L; antitumor immunity; gap junction; immunotransmitter; type I interferon.

Figures
Products